Note 5 — Stock-Based
Compensation
In August 2021, the Board
of Directors of the Company approved the fiscal year 2022 Long Term
Incentive Plan (“2022 LTIP”) for the executive officers and other
members of management. The 2022 LTIP is an equity-based plan with a
grant date of September 1, 2021 and contains (a) a restricted
stock grant of 9,584 shares in the aggregate (of which 3,304
included a performance-based vesting component and were subject to
adjustment as discussed below), with a vesting date of August 31,
2024, and (b) options to purchase 12,942 shares of common stock in
the aggregate with an exercise price of $114.50 per share, vesting
in three equal annual installments ending on August 31, 2024.
Based on the fiscal year 2022 results, 842 shares of restricted
stock were forfeited subsequent to the end of fiscal year 2022 in
accordance with not meeting the performance measurement criteria.
No further performance-based measurements apply to this award.
In August 2022, the Board of Directors of the Company approved the
fiscal year 2023 Long Term Incentive Plan (“2023 LTIP”) for
executive officers and other members of management. The 2023 LTIP
is an equity-based plan with a grant date of September 1, 2022 and
contains the following equity components:
Restricted Shares — (a) a
performance and service-based restricted stock grant of 10,580
shares in the aggregate, subject to adjustment based on fiscal 2023
results, with a vesting date of August 31, 2025. Compensation expense is
recognized on a ratable basis over the vesting period based on
quarterly probability assessments; and (b) a time-based
restricted stock grant of 9,918 shares and 636 shares, with
a vesting date of August 31, 2025 and August 31, 2023,
respectively. Compensation expense is being recognized on a ratable
basis over the vesting period. Additionally, the Board of Directors
approved a retention grant of time-based restricted stock grant of
10,015 shares in the aggregate. Out of the 10,015 shares of granted
time-based restricted stock, 2,056 shares vest on March 1, 2023,
3,705 shares vest on September 1, 2023, 1,418 shares vest on August
31, 2024, and 2,836 shares vest on August 31, 2026. Compensation
expense is being recognized on a ratable basis over the vesting
period.
Stock Options
— options to purchase
25,987 shares of common stock in the aggregate with an
exercise price of $88.16 per share. The options will
vest in three
equal annual installments beginning
on August 31, 2023 and ending on August 31, 2025. The
options will expire ten
years after the grant date.
Compensation expense is being recognized over the period of the
award consistent with the vesting terms.